Post Menopausal Osteoporosis
Conditions
Keywords
Procare, Post menopausal osteoporosis, Bisphosphonate, calcium, vitamin D, supplement
Brief summary
This study aims to evaluate the adherence of patients to combined treatment with bisphosphonates and calcium and vitamin D supplements, which is one of the usual treatments for postmenopausal osteoporosis. The study will consist of a single visit that will coincide with one of the patient's usual follow-up visits according to standard clinical practice. During this visit, information will be collected from the patient's medical history and an interview will be conducted using 3 questionnaires to assess how and how often the patient takes the treatment, possible forgetfulness, and whether or not the patient is satisfied with their current treatment.
Interventions
None listed
Sponsors
Procare Health Iberia S.L.
Study design
Observational model
OTHER
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
FEMALE
Healthy volunteers
No
Inclusion criteria
1. \- Women diagnosed with postmenopausal OP. 2. \- Women who had been prescribed oral treatment with a BP administered monthly or weekly together with a Ca/D supplement (sachets or chewable tablets) administered daily, at least 6 months prior to inclusion in the study. 3. \- Women who had given their written informed consent before participating in the study.
Exclusion criteria
None
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Intergroup adherence | Day 1 | To evaluate intergroup adherence to the most common oral regimens used in the treatment of postmenopausal OP that combine BP and Ca/D supplements, using a 8-items Morisky Medication Adherence Scale |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Adherence intragroup | Day 1 | To evaluate, intragroup, the adherence to the prescribed usual oral regimens, using a 8-items Morisky Medication Adherence Scale |
| Persistence intragroup | Day 1 | To evaluate, intragroup, the persistence to the prescribed usual oral regimens. |
| Persistence intergroup | Day 1 | To evaluate, intergroup, the persistence to the most common oral regimens used in the treatment of postmenopausal OP that combine BP and Ca/D supplements. It will be evaluated over time from the start of the combination of both until the first end date of administration of either one, and by the percentage of patients who continue with the combined treatment since its prescription |
| Factors of non-persistence | Day 1 | To evaluate possible determining factors of non-persistence to the prescribed usual oral regimens and their comparison between different regimens. |
| Treatment satisfaction | Day 1 | To evaluate the patient's satisfaction with the combined treatment received using a Likert scale. |
| Factors of non-adherence | Day 1 | To evaluate possible determining factors of non-adherence to the prescribed usual oral regimens and their comparison between the different regimens. |
Countries
Spain
Contacts
Primary ContactJosep Combalia
Outcome results
None listed